MACK

Merrimack Pharmaceuticals, Inc.
MACK

Overview Fund Activity
Delisted

MACK was delisted on the 17th of May, 2024.

Back to rankings

139 hedge funds and large institutions have $703M invested in Merrimack Pharmaceuticals, Inc. in 2016 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 52 increasing their positions, 35 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
139
Holders Change
–
Holders Change %
0%
% of All Funds
3.71%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
19
Increased
52
Reduced
35
Closed
19
Calls
$2.91M
Puts
$1.49M
Net Calls
+$1.42M
Net Calls Change
+$1.6M

Top Buyers

1
CCM
1
Consonance Capital Management
New York
$49.2M
2
Westfield Capital Management
2
Westfield Capital Management
Massachusetts
$68M
3
Renaissance Technologies
3
Renaissance Technologies
New York
$5.33M
4
PI
4
Putnam Investments
Massachusetts
$22.4M
5
TCIM
5
TIAA CREF Investment Management
New York
$45.7M

Top Sellers

1
Millennium Management
1
Millennium Management
New York
$0
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$77.3M
3
AIMCA
3
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$1.95M
4
State Street
4
State Street
Massachusetts
$24.9M
5
Connor, Clark & Lunn Investment Management (CC&L)
5
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$4.1M
Name Holding Trade Value Shares
Change 		Shares
Change %
SAM
151
Silvercrest Asset Management
New York
– -$198K -3,180 Closed
DC
152
Deere & Company
Illinois
– -$169K -2,723 Closed
PM
153
Parametrica Management
Hong Kong
– -$168K -2,698 Closed
LCM
154
Landscape Capital Management
New Jersey
– -$163K -2,629 Closed
FM
155
Family Management
New York
– -$95K -1,525 Closed
OC
156
Oppenheimer & Co
New York
– -$89K -1,436 Closed
CCMH
157
Cornerstone Capital Management Holdings
New York
– -$11K -178 Closed
CG
158
Cutler Group
California
– -$10K -172 Closed
3 4 5 6
7